What a study of Reddit posts says about retatrutide
Retatrutide has no approval, yet it is discussed widely online. In October 2026 a team at the University of Pennsylvania published a study of what people who post on Reddit say about it. Below are the numbers, where the study stops, and what it means for a lab buying the compound for research.
On this page
The study in numbers
The results were published on 14 October 2026 in JAMA Network Open as a peer-reviewed research letter: a cross-sectional AI analysis of self-reported posts, not a clinical trial. A preprint had been posted on medRxiv on 3 June 2026.
The team collected 148,640 Reddit posts and comments about retatrutide, written up to 31 December 2025. They came from retatrutide communities and from broader peptide and weight-management ones.
A validated language model then picked out 13,589 users who said they were currently using retatrutide. The researchers set aside the effects people expect: weight loss and appetite suppression. That left 7,823 users who described at least one other symptom. Every percentage on this page is a share of those 7,823.
What came up most
Increased appetite topped the list at 17.1%. Fatigue came next at 15.2%, then increased energy at 12.4% and nausea at 11.6%. Food craving (7.3%), insomnia (6.1%) and a faster heart rate (4.8%) completed the most common reports.
Some of these pull against each other. Increased appetite sits at the top, even though appetite suppression is one of the expected effects. Fatigue and increased energy both rank high. A study of posts cannot say why. It only shows what people chose to write about.
Why it differs from the trials
In the phase 2 trial, stomach and gut complaints were the most common adverse events: nausea, diarrhoea, vomiting and constipation. On Reddit they were common too, but they were not the top category.
The authors list several explanations other than the compound itself. Product quality and variable content per vial. Combining several unapproved peptides. How the powder was reconstituted. The profile of the users, since retatrutide is popular among weightlifters. And misattribution, where a symptom is blamed on the wrong cause.
The first item is the one a lab can do something about. If the vial does not hold what the label says, the work is no longer the experiment you planned.
What the study cannot tell you
The authors call the work hypothesis-generating only. It cannot show that retatrutide caused any symptom. It cannot say how often an effect happens, or whether more material leads to stronger effects.
Reddit users are not a representative group. People who have problems may post more than people who don't. And nobody can know the identity, purity or amount of the product each person had.
This page does not quote individual posts. Everything here comes from the published study.
What it means if you buy retatrutide for research
The study could not see what was in each vial. In a lab, that is the part you can control. Three habits help.
Read the certificate for content, not just purity. A vial can be 99% pure and still hold far less than its label. Our page on whether retatrutide is underdosed sets out what published lab reports show.
Treat a new supplier as a new variable. A different lot can mean different content per vial and different impurities. If you are partway through a series, read how to switch retatrutide supplier without losing comparability.
Match the lot number on the certificate to the vial. Every lot of RetaNord Retatrutide goes through a full 7-test panel, and the certificate is in the box.
Sources
- Sehgal NKR, Tronieri JS, Rader B, Ungar L, Guntuku SC. Self-Reported Adverse Effects Among Social Media Users Taking Nonapproved Retatrutide. JAMA Network Open (research letter), published online 14 October 2026. doi:10.1001/jamanetworkopen.2026.38929. doi.org
- Preprint on medRxiv (June 2026). www.medrxiv.org
- ScienceDaily, 21 Oct 2026. www.sciencedaily.com
Common questions
What do people on Reddit report about retatrutide?
In the University of Pennsylvania study, the most common symptoms beyond weight loss and appetite suppression were increased appetite (17.1%), fatigue (15.2%), increased energy (12.4%) and nausea (11.6%). These are shares of 7,823 users who described at least one such symptom.
Does the study prove retatrutide causes these effects?
No. The authors call it hypothesis-generating. It cannot show cause or how often effects happen, and the product each person had is unknown.
Why does product quality come up in the study?
The authors list product quality and variable content per vial among the possible explanations. Without lab data on each vial, a symptom cannot be tied to the compound itself.